Nothing Special   »   [go: up one dir, main page]
Skip to main content

Advertisement

Springer Nature Link
Log in

Fibroblast—Extracellular Matrix Interactions in Tissue Fibrosis

  • Matrix Pathobiology (Youhua Liu, Section Editor)
  • Published:
Current Pathobiology Reports

Abstract

Activated myofibroblasts are key effector cells in tissue fibrosis. Emerging evidence suggests that myofibroblasts infiltrating fibrotic tissues originate predominantly from local mesenchyme-derived populations. Alterations in the extracellular matrix network play an important role in modulating fibroblast phenotype and function. In a pro-inflammatory environment, generation of matrix fragments may induce a matrix-degrading fibroblast phenotype. Deposition of ED-A fibronectin plays an important role in myofibroblast transdifferentiation. In fibrotic tissues, the matrix is enriched with matricellular macromolecules that regulate growth factor-mediated responses and modulate protease activation. This manuscript discusses emerging concepts on the role of the extracellular matrix in regulation of fibroblast behavior.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214:199–210

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Dumont NA, Bentzinger CF, Sincennes MC et al (2015) Satellite cells and skeletal muscle regeneration. Compr Physiol 5:1027–1059

    Article  PubMed  Google Scholar 

  3. Frangogiannis NG (2015) Pathophysiology of myocardial infarction. Compr Physiol 5:1841–1875

    Article  PubMed  Google Scholar 

  4. • Duffield JS (2014) Cellular and molecular mechanisms in kidney fibrosis. J Clin Investig 124:2299–2306. A highly informative and well-illustrated review on the cell biology of renal fibrosis

  5. Kong P, Christia P, Frangogiannis NG (2014) The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 71:549–574

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18:1028–1040

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cavalera M, Wang J, Frangogiannis NG (2014) Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. Transl Res 164:323–335

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Leask A (2015) Matrix remodeling in systemic sclerosis. Semin Immunopathol 37:559–563

    Article  CAS  PubMed  Google Scholar 

  9. Biernacka A, Cavalera M, Wang J et al (2015) Smad3 signaling promotes fibrosis while preserving cardiac and aortic geometry in obese diabetic mice. Circ Heart Fail 8:788–798

    Article  CAS  PubMed  Google Scholar 

  10. Gabbiani G, Majno G (1972) Dupuytren’s contracture: fibroblast contraction?: an ultrastructural study. Am J Pathol 66:131–146

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Gabbiani G (2003) The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200:500–503

    Article  CAS  PubMed  Google Scholar 

  12. Hinz B (2007) Formation and function of the myofibroblast during tissue repair. J Investig Dermatol 127:526–537

    Article  CAS  PubMed  Google Scholar 

  13. Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Investig 112:1776–1784

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6:392–401

    Article  CAS  PubMed  Google Scholar 

  15. Zeisberg EM, Tarnavski O, Zeisberg M et al (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13:952–961

    Article  CAS  PubMed  Google Scholar 

  16. Bucala R, Spiegel LA, Chesney J et al (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71–81

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Pilling D, Buckley CD, Salmon M et al (2003) Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 171:5537–5546

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Haudek SB, Xia Y, Huebener P et al (2006) Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci USA 103:18284–18289

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Fausther M, Lavoie EG, Dranoff JA (2013) Contribution of myofibroblasts of different origins to liver fibrosis. Curr Pathobiol Rep 1:225–230

    Article  PubMed  PubMed Central  Google Scholar 

  20. Iwano M, Plieth D, Danoff TM et al (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Investig 110:341–350

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Osterreicher CH, Penz-Osterreicher M, Grivennikov SI et al (2011) Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc Natl Acad Sci USA 108:308–313

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Kong P, Christia P, Saxena A et al (2013) Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am J Physiol Heart Circ Physiol 305:H1363–H1372

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Dewald O, Zymek P, Winkelmann K et al (2005) CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 96:881–889

    Article  CAS  PubMed  Google Scholar 

  24. Frangogiannis NG (2007) Chemokines in ischemia and reperfusion. Thromb Haemost 97:738–747

    CAS  PubMed  Google Scholar 

  25. Keeley EC, Mehrad B, Strieter RM (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders. Thromb Haemost 101:613–618

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Lin SL, Kisseleva T, Brenner DA et al (2008) Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 173:1617–1627

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Scholten D, Reichart D, Paik YH et al (2011) Migration of fibrocytes in fibrogenic liver injury. Am J Pathol 179:189–198

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. • Rinkevich Y, Walmsley GG, Hu MS et al (2015) Skin fibrosis: identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science 348:aaa2151. This study identifies a dermal lineage with high fibrogenic potential. Ablation of these CD26+ cells attenuates cutaneous fibrosis

  29. Goritz C, Dias DO, Tomilin N et al (2011) A pericyte origin of spinal cord scar tissue. Science 333:238–242

    Article  PubMed  Google Scholar 

  30. Humphreys BD, Lin SL, Kobayashi A et al (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176:85–97

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/pericyte interactions. Circ Res 97:512–523

    Article  CAS  PubMed  Google Scholar 

  32. • Kramann R, Schneider RK, DiRocco DP et al (2015) Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 16:51–66. A seminal study, demonstrating that Gli1-positive perivascular cells contribute to myofibroblast populations in several different organs

  33. Nag AC (1980) Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios 28:41–61

    CAS  PubMed  Google Scholar 

  34. Souders CA, Bowers SL, Baudino TA (2009) Cardiac fibroblast: the renaissance cell. Circ Res 105:1164–1176

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. • Moore-Morris T, Guimaraes-Camboa N, Banerjee I et al (2014) Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J Clin Investig 124:2921–2934. A systematic study using lineage tracing approaches to study the origin of activated fibroblasts in the fibrotic pressure-overloaded myocardium demonstrates for the first time the crucial role of local resident fibroblast lineages

  36. Ali SR, Ranjbarvaziri S, Talkhabi M et al (2014) Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circ Res 115:625–635

    Article  CAS  PubMed  Google Scholar 

  37. Ruiz-Villalba A, Simon AM, Pogontke C et al (2015) Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar. J Am Coll Cardiol 65:2057–2066

    Article  PubMed  Google Scholar 

  38. Shinde AV, Frangogiannis NG (2014) Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol 70C:74–82

    Article  Google Scholar 

  39. Saxena A, Chen W, Su Y et al (2013) IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J Immunol 191:4838–4848

    Article  CAS  PubMed  Google Scholar 

  40. Mezzaroma E, Toldo S, Farkas D et al (2011) The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci USA 108:19725–19730

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Willems IE, Havenith MG, De Mey JG et al (1994) The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 145:868–875

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Cleutjens JP, Kandala JC, Guarda E et al (1995) Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27:1281–1292

    Article  CAS  PubMed  Google Scholar 

  43. Frangogiannis NG, Michael LH, Entman ML (2000) Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc Res 48:89–100

    Article  CAS  PubMed  Google Scholar 

  44. Bujak M, Ren G, Kweon HJ et al (2007) Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 116:2127–2138

    Article  CAS  PubMed  Google Scholar 

  45. Biernacka A, Dobaczewski M, Frangogiannis NG (2011) TGF-beta signaling in fibrosis. Growth Factors 29:196–202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Zymek P, Bujak M, Chatila K et al (2006) The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol 48:2315–2323

    Article  CAS  PubMed  Google Scholar 

  47. Porter KE, Turner NA (2009) Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 123:255–278

    Article  CAS  PubMed  Google Scholar 

  48. He W, Dai C (2015) Key fibrogenic signaling. Curr Pathobiol Rep 3:183–192

    Article  PubMed  PubMed Central  Google Scholar 

  49. Dobaczewski M, de Haan JJ, Frangogiannis NG (2012) The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium. J Cardiovasc Transl Res 5:837–847

    Article  PubMed  PubMed Central  Google Scholar 

  50. • Parker MW, Rossi D, Peterson M et al (2014) Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Investig 124:1622–1635. An interesting study suggesting that the fibrotic extracellular matrix drives fibroblast activation in idiopathic pulmonary fibrosis

  51. Smith RS, Smith TJ, Blieden TM et al (1997) Fibroblasts as sentinel cells: synthesis of chemokines and regulation of inflammation. Am J Pathol 151:317–322

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Bujak M, Dobaczewski M, Chatila K et al (2008) Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 173:57–67

    Article  PubMed  PubMed Central  Google Scholar 

  53. Clark RA, Wikner NE, Doherty DE et al (1988) Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment. J Biol Chem 263:12115–12123

    CAS  PubMed  Google Scholar 

  54. Huttenlocher A, Werb Z, Tremble P et al (1996) Decorin regulates collagenase gene expression in fibroblasts adhering to vitronectin. Matrix Biol 15:239–250

    Article  CAS  PubMed  Google Scholar 

  55. Kapila YL, Kapila S, Johnson PW (1996) Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. Matrix Biol 15:251–261

    Article  CAS  PubMed  Google Scholar 

  56. Kong W, Longaker MT, Lorenz HP (2004) Cyclophilin C-associated protein is a mediator for fibronectin fragment-induced matrix metalloproteinase-13 expression. J Biol Chem 279:55334–55340

    Article  CAS  PubMed  Google Scholar 

  57. Campo GM, Avenoso A, D’Ascola A et al (2012) The inhibition of hyaluronan degradation reduced pro-inflammatory cytokines in mouse synovial fibroblasts subjected to collagen-induced arthritis. J Cell Biochem 113:1852–1867

    Article  CAS  PubMed  Google Scholar 

  58. David-Raoudi M, Tranchepain F, Deschrevel B et al (2008) Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing. Wound Repair Regen 16:274–287

    Article  PubMed  Google Scholar 

  59. Dobaczewski M, Bujak M, Zymek P et al (2006) Extracellular matrix remodeling in canine and mouse myocardial infarcts. Cell Tissue Res 324:475–488

    Article  CAS  PubMed  Google Scholar 

  60. Welch MP, Odland GF, Clark RA (1990) Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol 110:133–145

    Article  CAS  PubMed  Google Scholar 

  61. Kuhn C 3rd, Boldt J, King TE Jr et al (1989) An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 140:1693–1703

    Article  PubMed  Google Scholar 

  62. Clark RA (1995) Wound repair: overview and general considerations. In: Raf C (ed) The molecular and cellular biology of wound repair. Plenum Press, New York, pp 3–50

  63. Rybarczyk BJ, Lawrence SO, Simpson-Haidaris PJ (2003) Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration. Blood 102:4035–4043

    Article  CAS  PubMed  Google Scholar 

  64. Greiling D, Clark RA (1997) Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 110(Pt 7):861–870

    CAS  PubMed  Google Scholar 

  65. Lin F, Ren XD, Doris G et al (2005) Three-dimensional migration of human adult dermal fibroblasts from collagen lattices into fibrin/fibronectin gels requires syndecan-4 proteoglycan. J Investig Dermatol 124:906–913

    Article  CAS  PubMed  Google Scholar 

  66. Corbett SA, Schwarzbauer JE (1998) Fibronectin-fibrin cross-linking: a regulator of cell behavior. Trends Cardiovasc Med 8:357–362

    Article  CAS  PubMed  Google Scholar 

  67. Li X, Qian H, Ono F et al (2014) Human dermal fibroblast migration induced by fibronectin in autocrine and paracrine manners. Exp Dermatol 23:682–684

    Article  CAS  PubMed  Google Scholar 

  68. Lin F, Ren XD, Pan Z et al (2011) Fibronectin growth factor-binding domains are required for fibroblast survival. J Investig Dermatol 131:84–98

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Serini G, Bochaton-Piallat ML, Ropraz P et al (1998) The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 142:873–881

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Naugle JE, Olson ER, Zhang X et al (2006) Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. Am J Physiol Heart Circ Physiol 290:H323–H330

    Article  CAS  PubMed  Google Scholar 

  71. Luther DJ, Thodeti CK, Shamhart PE et al (2012) Absence of type VI collagen paradoxically improves cardiac function, structure, and remodeling after myocardial infarction. Circ Res 110:851–856

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Webber J, Meran S, Steadman R et al (2009) Hyaluronan orchestrates transforming growth factor-beta1-dependent maintenance of myofibroblast phenotype. J Biol Chem 284:9083–9092

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Meran S, Thomas D, Stephens P et al (2007) Involvement of hyaluronan in regulation of fibroblast phenotype. J Biol Chem 282:25687–25697

    Article  CAS  PubMed  Google Scholar 

  74. Midgley AC, Rogers M, Hallett MB et al (2013) Transforming growth factor-beta1 (TGF-beta1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts. J Biol Chem 288:14824–14838

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Huebener P, Abou-Khamis T, Zymek P et al (2008) CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J Immunol 180:2625–2633

    Article  CAS  PubMed  Google Scholar 

  76. Yuen A, Laschinger C, Talior I et al (2010) Methylglyoxal-modified collagen promotes myofibroblast differentiation. Matrix Biol 29:537–548

    Article  CAS  PubMed  Google Scholar 

  77. Bornstein P (2009) Matricellular proteins: an overview. J Cell Commun Signal 3:163–165

    Article  PubMed  PubMed Central  Google Scholar 

  78. Frangogiannis NG (2012) Matricellular proteins in cardiac adaptation and disease. Physiol Rev 92:635–688

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Xia Y, Dobaczewski M, Gonzalez-Quesada C et al (2011) Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism. Hypertension 58:902–911

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Adams JC, Lawler J (2004) The thrombospondins. Int J Biochem Cell Biol 36:961–968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Zeisberg M, Tampe B, LeBleu V et al (2014) Thrombospondin-1 deficiency causes a shift from fibroproliferative to inflammatory kidney disease and delays onset of renal failure. Am J Pathol 184:2687–2698

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Ribeiro SM, Poczatek M, Schultz-Cherry S et al (1999) The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 274:13586–13593

    Article  CAS  PubMed  Google Scholar 

  83. Gonzalez-Quesada C, Cavalera M, Biernacka A et al (2013) Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation. Circ Res 113:1331–1344

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Rodriguez-Manzaneque JC, Lane TF, Ortega MA et al (2001) Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci USA 98:12485–12490

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Hogg PJ (1994) Thrombospondin 1 as an enzyme inhibitor. Thromb Haemost 72:787–792

    CAS  PubMed  Google Scholar 

  86. Carey WA, Taylor GD, Dean WB et al (2010) Tenascin-C deficiency attenuates TGF-ss-mediated fibrosis following murine lung injury. Am J Physiol Lung Cell Mol Physiol 299:L785–L793

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Shimojo N, Hashizume R, Kanayama K et al (2015) Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin alphaVbeta3/nuclear factor-kappaB/interleukin-6 axis. Hypertension 66:757–766

    Article  CAS  PubMed  Google Scholar 

  88. Tamaoki M, Imanaka-Yoshida K, Yokoyama K et al (2005) Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol 167:71–80

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. De Laporte L, Rice JJ, Tortelli F et al (2013) Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain. PLoS One 8:e62076

    Article  PubMed  PubMed Central  Google Scholar 

  90. Schellings MW, Vanhoutte D, Swinnen M et al (2009) Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction. J Exp Med 206:113–123

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Ashizawa N, Graf K, Do YS et al (1996) Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J Clin Investig 98:2218–2227

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Lorenzen JM, Schauerte C, Hubner A et al (2015) Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis. Eur Heart J 36:2184–2196

    Article  PubMed  PubMed Central  Google Scholar 

  93. Wu M, Schneider DJ, Mayes MD et al (2012) Osteopontin in systemic sclerosis and its role in dermal fibrosis. J Investig Dermatol 132:1605–1614

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Zohar R, Zhu B, Liu P et al (2004) Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3-independent pathway. Am J Physiol Heart Circ Physiol 287:H1730–H1739

    Article  CAS  PubMed  Google Scholar 

  95. Anwar A, Li M, Frid MG et al (2012) Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 303:L1–L11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Shimazaki M, Nakamura K, Kii I et al (2008) Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 205:295–303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Crawford J, Nygard K, Gan BS et al (2015) Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring. Exp Dermatol 24:120–126

    Article  CAS  PubMed  Google Scholar 

  98. Chen Y, Abraham DJ, Shi-Wen X et al (2004) CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell 15:5635–5646

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Dobaczewski M, Bujak M, Li N et al (2010) Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res 107:418–428

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Xu H, Li P, Liu M et al (2015) CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-beta. Clin Exp Pharmacol Physiol 42:1207–1219

    Article  CAS  PubMed  Google Scholar 

  101. Liu S, Shi-wen X, Abraham DJ et al (2011) CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum 63:239–246

    Article  CAS  PubMed  Google Scholar 

  102. Leask A (2015) Getting to the heart of the matter: new insights into cardiac fibrosis. Circ Res 116:1269–1276

    Article  CAS  PubMed  Google Scholar 

  103. • Kim KH, Chen CC, Monzon RI et al (2013) Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol Cell Biol 33:2078–2090. An important study that documents anti-fibrotic effects of the matricellular protein CCN1 in the liver in models of carbon tetrachloride intoxication and bile duct ligation

  104. Borkham-Kamphorst E, Schaffrath C, Van de Leur E et al (2014) The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-beta signaling. Biochim Biophys Acta 1843:902–914

    Article  CAS  PubMed  Google Scholar 

  105. Yoon PO, Lee MA, Cha H et al (2010) The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. J Mol Cell Cardiol 49:294–303

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Dr Frangogiannis’ laboratory is supported by NIH Grants R01 HL76246 and R01 HL85440.

Author information

Authors and Affiliations

  1. Department of Medicine (Cardiology), The Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, 1300 Morris Park Avenue Forchheimer G46B, Bronx, NY, 10461, USA

    Nikolaos G. Frangogiannis

Authors
  1. Nikolaos G. Frangogiannis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nikolaos G. Frangogiannis.

Additional information

This article is part of the Topical Collection on Matrix Pathobiology.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frangogiannis, N.G. Fibroblast—Extracellular Matrix Interactions in Tissue Fibrosis. Curr Pathobiol Rep 4, 11–18 (2016). https://doi.org/10.1007/s40139-016-0099-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40139-016-0099-1

Keywords

Search

Navigation